Pfizer Net Income Quarterly:
2.75B for Dec. 31, 2012Pfizer Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 2.75B |
| Dec. 31, 2012 | 6.315B |
| Sept. 30, 2012 | 3.208B |
| June 30, 2012 | 3.253B |
| March 31, 2012 | 1.794B |
| Dec. 31, 2011 | 1.439B |
| Sept. 30, 2011 | 3.738B |
| June 30, 2011 | 2.61B |
| March 31, 2011 | 2.222B |
| Dec. 31, 2010 | 2.89B |
| Sept. 30, 2010 | 866.00M |
| June 30, 2010 | 2.475B |
| March 31, 2010 | 2.026B |
| Dec. 31, 2009 | 767.00M |
| Sept. 30, 2009 | 2.878B |
| June 30, 2009 | 2.261B |
| March 31, 2009 | 2.729B |
| Dec. 31, 2008 | 266.00M |
| Sept. 30, 2008 | 2.278B |
| June 30, 2008 | 2.776B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
PFE Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Johnson & Johnson | 3.497B |
| Merck | 1.593B |
| Bristol-Myers Squibb | 609.00M |
PFE Net Income Quarterly Rankings
| Overall |
99th percentile 34 of 8007 |
| Sector |
99th percentile 2 of 685 in Healthcare |
| Industry |
96th percentile 2 of 54 in Drug Manufacturers - Major |
PFE Net Income Quarterly Range, Past 5 Years
| Minimum | 266.00M | Dec 2008 |
| Maximum | 6.315B | Dec 2012 |
| Average | 2.477B |